.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Multimodality Management of Advanced Liver Cancer

EP. 1: Liver Pathobiology's Role in Hepatocellular Carcinoma

October 23rd 2019

EP. 2: Implications for I/O Therapy in the Treatment of HCC

October 23rd 2019

EP. 3: Hepatocellular Carcinoma: Antiangiogenic Therapy Options

October 23rd 2019

EP. 4: Optimal Use of Second-Line TKIs in Hepatocellular Carcinoma

October 23rd 2019

EP. 5: Elevated AFP in Relapsed/Refractory Metastatic HCC

October 23rd 2019

EP. 6: I/O Combination Strategies in Hepatocellular Carcinoma

October 23rd 2019

EP. 7: Optimal Sequencing of I/O Therapy in Liver Cancer

October 23rd 2019

EP. 8: Perioperative Approaches to HCC Management

October 23rd 2019

EP. 9: Hepatocellular Carcinoma: Future Directions in Care

October 23rd 2019